Synthesis and urease inhibition studies of barbituric and thiobarbituric acid derived sulphonamides

Journal of the Chinese Chemical Society

Volumn 58, Issue 4, 2011, Pages 528-537

  Rauf, A ^a   Ahmed, F ^a   Qureshi, A M ^b   Aziz Ur Rehman, ^a   Khan, A ^c   Qadir, M I ^c   Choudhary, M I ^c   Chohan, Z H ^b   Youssoufi, M H ^d   Ben Hadda, T ^d  

^a THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

^b BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^c UNIVERSITY OF KARACHI   (Pakistan)

^d FACULTÉ DES SCIENCES   (Morocco)

Author keywords

Antiurease; Barbituric and thiobarbituric acids based sulphonamides

Indexed keywords

EID: 80053421132     PISSN: 00094536     EISSN: None     Source Type: Journal    
DOI: 10.1002/jccs.201190017     Document Type: Article

References (24)

1. Mobley, H. L. T.; Island, M. D.; Hausinger, R. P. Microbiol. Rev. 1989, 53, 85.
2. Zonia, L. E.; Stebbins, N. E.; Polacco, J. C. Plant Physiol. 1995, 107, 1097.
3. Mulvaney, R. L.; Bremner, J. M. Soil Biochemistry; Marcel Dekker, Inc.: New York, 1981; p 153.
4. Mobley, H. L. T.; Island, M. D.; Hausinger, R. P. Microbiol. Rev. 1995, 59, 451.
5. Bayerdorffer, E.; Ottenjhan, R. Scand. J. Gastroenterol. 1988, 25, 93.
6. Chohan, Z. H.; Shaikh, A. U.; Rauf, A.; Supran, C. T. J. Enz. Inhib. Med. Chem. 2006, 21, 747.
7. Lednicer, D.; Mitscher, L. A. The Organic Chemistry of Drug Synthesis; John Wiley & Son Inc.: New York, 1977; p 1.
8. Gary, C. T.; Gerhart, J. C.; Brooke, M. S. Nature 1959, 184, 1936.
9. Gary, C. T.; Gerhart, J. C.; Brooke, M. S. J. Bacteriol. 1961, 81, 155.
10. Nishimori, I. S.; Minakuchi, T.; Kohsaki, T.; Onishi, S.; Takeuchi, H.; Vullo, D.; Scozzafava, A.; Supuran, C. T. Bioorg. Med. Chem. Lett. 2007, 17, 3585.
11. Tanaka, T.; Kawase, M.; Tani, S. Life Sci. 2003, 73, 2985.
12. thed.; Dorling Kinderseley: New Delhi, India, 2007; Vol. II, p 641.
13. Khan, K. M.; Iqbal, S.; Lodhi, M. A.; Maharvi, G M.; Zia-Ullah; Choudhary, M. I.; Atta-ur-rehman; Perveen, S. Bioorg. Med. Chem. 2004, 12, 1963.
14. (a) Bullock, A. N.; Atilla, G E.; Williams, D. S.; Bregman, H.; Knapp, S.; Meggers, E. Angew. Chem. Int. Ed. 2006, 45, 1580.
15. (b) Meggers, E. Curr Opin. Chem. Bio. 2007, 11, 287.
16. (c) Bregman, H.; Williams, D. S.; Atilla, G E.; Carroll, P. J.; Meggers, E. J. Am. Chem. Soc. 2004, 126, 13594.
17. (d) Meggers, E.; Atilla-Gokcumen, G E.; Bregman, H.; Maksimoska, J.; Mulcahy, S. P.; Pagano, N.; Williams, D. S. Synlett 2007, 8, 1177.
18. (e) Pagano, N.; Maksimoska, J.; Bregman, H.; Williams, D. S.; Webster, R. D.; Xuec, F.; Meggers, E. Org. Biomol. Chem. 2007, 5, 1218.
19. (f) Zhang, L.; Carroll, P.; Meggers, E. Org. Lett. 2004, 6, 521.
20. (g) Mulcahy, S. P.; Carroll, P. J.; Meggers, E. Tet. Lett. 2006, 47, 8877.
21. Koehn, F. E.; Carter, G T. Nat. Rev. Drug. Dis. 2005, 4, 206.
22. Carroll, A. R.; Quinn, R. J.; Pham, N. B.; Pierens, G K.; Muresan, S.; Suraweera, L.; Palframan, M. E.; Baron, P.; Neve, J. E. Congress of Drug Design Amongst The Vines; Hunter Valley, NSW: Australia, 2006; p 3.
23. Note: The OSIRIS Property Explorer shown in this page is an integral part of Actelion's inhouse substance registration system. It lets you draw chemical structures and calculates on-the-fly various drug-relevant properties whenever a structure is valid. Prediction results are valued and color coded. Properties with high risks of undesired effects like mutagenicity or a poor intestinal absorption are shown in red. Whereas a green color indicates drug-conform behaviour. http://www.organic-chemistry.org/prog/peo/ (Accessed date January 2010).
24. Ertl, P.; Rohde, B.; Selzer, P. J. Med. Chem. 2000, 43, 3714 http://www.molinspiration. com/services/ (Accessed date January 2010).